Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2730
-0.0220 (-7.46%)
At close: Sep 25, 2026, 4:00 PM EDT
0.2620
-0.0110 (-4.03%)
After-hours: Sep 25, 2026, 7:57 PM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $12.11 million as of September 25, 2026. Its market cap has decreased by -88.62% in one year.
Market Cap
12.11M
Enterprise Value
-18.83M
1-Year Change
-88.62%
Ranking
Category
Stock Price
$0.27
ChartMarket Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $12.11M, an increase of 30.27%. That is a compound annual growth rate of 2.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 12.10M | -53.64% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 12.85M |
| Pluri | 12.47M |
| GT Biopharma | 12.43M |
| Intensity Therapeutics | 12.41M |
| BioVie | 12.11M |
| CalciMedica | 11.95M |
| Daré Bioscience | 11.86M |
| IN8bio | 11.83M |